google1cd7abaa8d26ae66.html

PRACTITIONER ONLY

 

JULY, 2025

MAINTRAC ONLINE FORUM Q2

Personalised Therapy Monitoring in Colorectal Cancer Patients.

Prof. Katharina Pachamnn (Germany)


MARCH, 2025

MAINTRAC ONLINE FORUM Q1

Using Stemtrac® to assess tumor aggressiveness & recurrence risk

Prof. Katharina Pachamnn (Germany)


DECEMBER, 2024

MAINTRAC ONLINE FORUM Q4

Maintrac and Stemtrac – Answers to the Most Frequently Asked Questions

Prof. Katharina Pachamnn (Germany)
Dr. Joachim Fluhrer (Australia)


JULY, 2024

MAINTRAC ONLINE FORUM Q2

Clinical Applications of Maintrac and Stemtrac Testing in Everday Practice

Prof. Katharina Pachamnn (Germany)
Dr. Joachim Fluhrer (Australia)


MARCH, 2024

MAINTRAC ONLINE FORUM Q1

How can the determination of tumor cell characteristics be used to support cancer therapy?

Prof. Katharina Pachamnn (Germany)


OCTOBER, 2023

MAINTRAC ONLINE FORUM Q4

HOW MAINTRAC® CAN BE USED TO SUPPORT BREAST CANCER THERAPY

Prof. Katharina Pachamnn (Germany)

Dr. Joachim Fluhrer (Australia)


JULY, 2023

MAINTRAC ONLINE FORUM Q3

THERAPEUTIC SUBSTANCE TESTING ON CIRCULATING EPITHELIAL TUMOR CELLS

Prof. Katharina Pachamnn (Germany)

Julia Meckel


MAY, 2023

MAINTRAC ONLINE FORUM Q2

CHANGES IN THE NUMBER OF CIRCULATING EPITHELIAL TUMOR CELLS DURING RADIATION THERAPY

Prof. Katharina Pachamnn (Germany)

Dr. Joachim Fluhrer (Australia)


January, 2023

MAINTRAC ONLINE FORUM Q1

Testing of circulating tumor stem cells by stemtrac® to assess tumor aggressiveness and risk of metastasis.

Dr. Monika Pizon


Watch more…

Monitoring Your Cancer Patient - CTC’s When What and Why?

Prof. Katharina Pachamnn (Germany)

Dr. Joachim Fluhrer (Australia)


Systems Approach to Cancer in Practice - Bringing Data(r) to Life.

Dr Nina Fuller-Shavel


Make it stand out

EXACTA® - The Most Comprehensive Tumour Testing Available Now.

Dr Nina Fuller-Shavel
Dr Tony Dhillon
Dr Stefan Schuster


REPURPOSED DRUGS IN CANCER MANAGEMENT.

Dr Barbara Fougere